Viewing Study NCT02714205


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-04-23 @ 5:02 PM
Study NCT ID: NCT02714205
Status: COMPLETED
Last Update Posted: 2025-03-28
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Flushing Reduction Associated With Nitrates
Sponsor: Alison Huang, MD
Organization:

Study Overview

Official Title: Flushing Reduction Associated With Nitrates
Status: COMPLETED
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FRAN
Brief Summary: A randomized, double-blinded, placebo-controlled trial of uninterrupted transdermal nitrate therapy in 140 peri- or postmenopausal women who have frequent hot flashes. Women will be randomly assigned to uninterrupted use of transdermal nitrate therapy (participant directed dose-escalation of 0.2 to 0.6 mg/hr) or identical-appearing placebo patches for 12 weeks.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
5R01AG050588-04 NIH None https://reporter.nih.gov/quic… View